CORIUM, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://corium.com
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
- Conditions
- Attention Deficit/Hyperactivity Disorder
- Interventions
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Corium, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT05721235
- Locations
- 🇺🇸
Preferred Research Partners (PRP), Little Rock, Arkansas, United States
🇺🇸Advanced Research Center (ARC), Anaheim, California, United States
🇺🇸IMMUNOe International Research Center, Centennial, Colorado, United States
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
- Conditions
- Attention Deficit/Hyperactivity Disorder
- Interventions
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Corium, Inc.
- Target Recruit Count
- 246
- Registration Number
- NCT05685732
- Locations
- 🇺🇸
Preferred Research Partners (PRP), Little Rock, Arkansas, United States
🇺🇸Advanced Research Center (ARC), Anaheim, California, United States
🇺🇸IMMUNOe International Research Center, Centennial, Colorado, United States
Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers
- Conditions
- Healthy Subjects
- Interventions
- Combination Product: Donepezil TDS
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Corium, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04617782
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- Corium, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03438604
- Locations
- 🇺🇸
Celerion, Phoenix, Arizona, United States
A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Corium, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT03432195
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
- Prev
- 1
- 2
- Next